Italia -
italia -
AIFA (Agenzia Italiana del Farmaco)
alfa bergamon
perrigo italia s.r.l. - didecildimetilammonio cloruro - didecildimetilammonio cloruro
Italia -
italia -
AIFA (Agenzia Italiana del Farmaco)
farmasept
nuova farmec s.r.l. - didecildimetilammonio cloruro - didecildimetilammonio cloruro
Italia -
italia -
AIFA (Agenzia Italiana del Farmaco)
septidil
nuova farmec s.r.l. - didecildimetilammonio cloruro - didecildimetilammonio cloruro
Italia -
italia -
AIFA (Agenzia Italiana del Farmaco)
dimetilfumarato piramal
piramal critical care italia s.p.a. - dimethyl fumarate - dimethyl fumarate
Euroopan unioni -
italia -
EMA (European Medicines Agency)
skilarence
almirall s.a - dimetilfumarato - psoriasi - immunosoppressori - skilarence è indicato per il trattamento della psoriasi a placche da moderata a grave negli adulti che necessitano di terapia medicinale sistemica.
Euroopan unioni -
italia -
EMA (European Medicines Agency)
tecfidera
biogen netherlands b.v. - dimetilfumarato - sclerosi multipla - immunosoppressori - tecfidera is indicated for the treatment of adult and paediatric patients aged 13 years and older with relapsing remitting multiple sclerosis (rrms).
Euroopan unioni -
italia -
EMA (European Medicines Agency)
dimethyl fumarate teva
teva gmbh - dimetilfumarato - multiple sclerosis, relapsing-remitting; multiple sclerosis - immunosoppressori - dimethyl fumarate teva is indicated for the treatment of adult and paediatric patients aged 13 years and older with relapsing remitting multiple sclerosis (rrms).
Euroopan unioni -
italia -
EMA (European Medicines Agency)
dimethyl fumarate accord
accord healthcare s.l.u. - dimetilfumarato - multiple sclerosis, relapsing-remitting; multiple sclerosis - immunosoppressori - dimethyl fumarate accord is indicated for the treatment of adult and paediatric patients aged 13 years and older with relapsing remitting multiple sclerosis (rrms).
Euroopan unioni -
italia -
EMA (European Medicines Agency)
dimethyl fumarate mylan
mylan ireland limited - dimetilfumarato - sclerosi multipla recidivante-remittente - immunosoppressori - dimethyl fumarate mylan is indicated for the treatment of adult patients with relapsing remitting multiple sclerosis.
Euroopan unioni -
italia -
EMA (European Medicines Agency)
dimethyl fumarate polpharma
zaklady farmafarmaceutyczne polpharma s.aceutyczne polpharma s.a. - dimetilfumarato - sclerosi multipla recidivante-remittente - immunosoppressori - dimethyl fumarate polpharma is indicated for the treatment of adult patients with relapsing remitting multiple sclerosis.